136 research outputs found

    Gold surfaces for condensation heat transfer

    Get PDF

    Development Of An Engineered Bioluminescent Reporter Phage For Detection Of Bacterial Blight Of Crucifers

    Get PDF
    Bacterial blight, caused by the phytopathogen Pseudomonas cannabina pv. alisalensis, is an emerging disease afflicting important members of the Brassicaceae family. The disease is often misdiagnosed as pepper spot, a much less severe disease caused by the related pathogen Pseudomonas syringae pv. maculicola. We have developed a phage-based diagnostic that can both identify and detect the causative agent of bacterial blight and differentiate the two pathogens. A recombinant >light>-tagged reporter phage was generated by integrating bacterial luxAB genes encoding luciferase into the genome of P. cannabina pv. alisalensis phage PBSPCA1. The PBSPCA1::luxAB reporter phage is viable and stable and retains properties similar to those of the wildtype phage. PBSPCA1::luxAB rapidly and sensitively detects P. cannabina pv. alisalensis by conferring a bioluminescent signal response to cultured cells. Detection is dependent on cell viability. Other bacterial pathogens of Brassica species such as P. syringae pv. maculicola, Pseudomonas marginalis, Pectobacterium carotovorum, Xanthomonas campestris pv. campestris, and X. campestris pv. raphani either do not produce a response or produce significantly attenuated signals with the reporter phage. Importantly, the reporter phage detects P. cannabina pv. alisalensis on diseased plant specimens, indicating its potential for disease diagnosis.National Science Foundation Small Business Innovative Research 1012059U.S. Department of EducationU.S. Department of AgricultureCellular and Molecular Biolog

    Critical Rayleigh Numbers for Natural Convection of Water Confined in Spare Cells With L/D From 0.5 to 8

    Get PDF
    An experimental study of heat, transfer modes in water heate

    Correlation of Pool Boiling Curves for the Homologous Group: Freons

    Get PDF
    Nomenclature C L = specific heat of liquid g = gravitational acceleration h fg = latent heat of evaporation k L = thermal conductivity of liquid P c = thermodynamic critical pressure <7> <7max> tfmin = heat flux, maximum flux, minimum flux Introduction A knowledge of the complete boiling curve q versus AT for a liquid, including the regimes of nucleate boiling, transition boiling, and film boiling, and the peak and minimum crisis points is needed for the design and operation of various types of heat transfer equipment. No general method exists for predicting the complete curve. Most difficult is the prediction of the nucleate boiling curve, the transition curve, and the temperature that separates the two. If the curve for every liquid at every pressure must be determined experimentally, we are faced with a formidable task. This paper shows that some simplification is possible for members of a homologous group

    Critical Exponents, Hyperscaling and Universal Amplitude Ratios for Two- and Three-Dimensional Self-Avoiding Walks

    Get PDF
    We make a high-precision Monte Carlo study of two- and three-dimensional self-avoiding walks (SAWs) of length up to 80000 steps, using the pivot algorithm and the Karp-Luby algorithm. We study the critical exponents Îœ\nu and 2Δ4−γ2\Delta_4 -\gamma as well as several universal amplitude ratios; in particular, we make an extremely sensitive test of the hyperscaling relation dÎœ=2Δ4−γd\nu = 2\Delta_4 -\gamma. In two dimensions, we confirm the predicted exponent Îœ=3/4\nu = 3/4 and the hyperscaling relation; we estimate the universal ratios  / =0.14026±0.00007\ / \ = 0.14026 \pm 0.00007,  / =0.43961±0.00034\ / \ = 0.43961 \pm 0.00034 and ι∗=0.66296±0.00043\Psi^* = 0.66296 \pm 0.00043 (68\% confidence limits). In three dimensions, we estimate Îœ=0.5877±0.0006\nu = 0.5877 \pm 0.0006 with a correction-to-scaling exponent Δ1=0.56±0.03\Delta_1 = 0.56 \pm 0.03 (subjective 68\% confidence limits). This value for Îœ\nu agrees excellently with the field-theoretic renormalization-group prediction, but there is some discrepancy for Δ1\Delta_1. Earlier Monte Carlo estimates of Îœ\nu, which were ≈ ⁣0.592\approx\! 0.592, are now seen to be biased by corrections to scaling. We estimate the universal ratios  / =0.1599±0.0002\ / \ = 0.1599 \pm 0.0002 and ι∗=0.2471±0.0003\Psi^* = 0.2471 \pm 0.0003; since ι∗>0\Psi^* > 0, hyperscaling holds. The approach to ι∗\Psi^* is from above, contrary to the prediction of the two-parameter renormalization-group theory. We critically reexamine this theory, and explain where the error lies.Comment: 87 pages including 12 figures, 1029558 bytes Postscript (NYU-TH-94/09/01

    Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases

    Get PDF
    Current antibiotics tend to be broad spectrum, leading to indiscriminate killing of commensal bacteria and accelerated evolution of drug resistance. Here, we use CRISPR-Cas technology to create antimicrobials whose spectrum of activity is chosen by design. RNA-guided nucleases (RGNs) targeting specific DNA sequences are delivered efficiently to microbial populations using bacteriophage or bacteria carrying plasmids transmissible by conjugation. The DNA targets of RGNs can be undesirable genes or polymorphisms, including antibiotic resistance and virulence determinants in carbapenem-resistant Enterobacteriaceae and enterohemorrhagic Escherichia coli. Delivery of RGNs significantly improves survival in a Galleria mellonella infection model. We also show that RGNs enable modulation of complex bacterial populations by selective knockdown of targeted strains based on genetic signatures. RGNs constitute a class of highly discriminatory, customizable antimicrobials that enact selective pressure at the DNA level to reduce the prevalence of undesired genes, minimize off-target effects and enable programmable remodeling of microbiota.National Institutes of Health (U.S.) (New Innovator Award 1DP2OD008435)National Centers for Systems Biology (U.S.) (Grant 1P50GM098792)United States. Defense Threat Reduction Agency (HDTRA1-14-1-0007)Massachusetts Institute of Technology. Institute for Soldier Nanotechnologies (W911NF13D0001)National Institute of General Medical Sciences (U.S.) (Interdepartmental Biotechnology Training Program 5T32 GM008334)Fonds de la recherche en sante du Quebec (Master's Training Award

    Is food addiction a predictor of treatment outcome among patients with eating disorder?

    Full text link
    ObjectivesThe study aimed to examine whether food addiction (FA) was associated with greater severity in both binge eating disorders (BED) and bulimia nervosa and, therefore, to determine if FA was predictive of treatment outcome.MethodSeventy-one adult patients with bulimia nervosa and BED (42 and 29, respectively) participated in the study. FA was assessed by means of the Yale Food Addiction Scale.ResultsThe results confirmed a high prevalence of FA in patients with binge disorders (around 87%) and also its association with a greater severity of the disorder (i.e., related to an increased eating psychopathology and greater frequency of binge eating episodes). Although FA did not appear as a predictor of treatment outcome in general terms, when the diagnostic subtypes were considered separately, FA was associated with poor prognosis in the BED group. In this vein, FA appeared as a mediator in the relationship between ED severity and treatment outcome.DiscussionsOur findings suggest that FA may act as an indicator of ED severity, and it would be a predictor of treatment outcome in BED but not in BN.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152018/1/erv2705.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/152018/2/erv2705_am.pd

    Developing 1D nanostructure arrays for future nanophotonics

    Get PDF
    There is intense and growing interest in one-dimensional (1-D) nanostructures from the perspective of their synthesis and unique properties, especially with respect to their excellent optical response and an ability to form heterostructures. This review discusses alternative approaches to preparation and organization of such structures, and their potential properties. In particular, molecular-scale printing is highlighted as a method for creating organized pre-cursor structure for locating nanowires, as well as vapor–liquid–solid (VLS) templated growth using nano-channel alumina (NCA), and deposition of 1-D structures with glancing angle deposition (GLAD). As regards novel optical properties, we discuss as an example, finite size photonic crystal cavity structures formed from such nanostructure arrays possessing highQand small mode volume, and being ideal for developing future nanolasers

    Phage engineering: how advances in molecular biology and synthetic biology are being utilized to enhance the therapeutic potential of bacteriophages

    Get PDF
    Background The therapeutic potential of bacteriophages has been debated since their first isolation and characterisation in the early 20th century. However, a lack of consistency in application and observed efficacy during their early use meant that upon the discovery of antibiotic compounds research in the field of phage therapy quickly slowed. The rise of antibiotic resistance in bacteria and improvements in our abilities to modify and manipulate DNA, especially in the context of small viral genomes, has led to a recent resurgence of interest in utilising phage as antimicrobial therapeutics. Results In this article a number of results from the literature that have aimed to address key issues regarding the utility and efficacy of phage as antimicrobial therapeutics utilising molecular biology and synthetic biology approaches will be introduced and discussed, giving a general view of the recent progress in the field. Conclusions Advances in molecular biology and synthetic biology have enabled rapid progress in the field of phage engineering, with this article highlighting a number of promising strategies developed to optimise phages for the treatment of bacterial disease. Whilst many of the same issues that have historically limited the use of phages as therapeutics still exist, these modifications, or combinations thereof, may form a basis upon which future advances can be built. A focus on rigorous in vivo testing and investment in clinical trials for promising candidate phages may be required for the field to truly mature, but there is renewed hope that the potential benefits of phage therapy may finally be realised
    • 

    corecore